Former NuVasive CEO to exit board

Laura Dyrda -   Print  |
Listen

Gregory Lucier will retire from the company's board of directors May 18.

 

Mr. Lucier joined the board in 2013 and became chairman and CEO in 2015. He left his role as CEO in November 2018 after growing the company's net sales to more than $1 billion. NuVasive also built a manufacturing facility in West Carrollton, Ohio, during Mr. Lucier's tenure. The company began developing the X360 system for lateral single-position spine surgery and the Pulse integrated surgical technologies platform.

"I want to thank Greg for his leadership and guidance to NuVasive and the board of directors. His extensive medical device background and experience commercializing disruptive technology helped expand the company's key growth areas and build a strong foundation for our long-term strategy," said NuVasive CEO J. Christopher Barry.

Mr. Lucier launched Corza Health, a San Diego-based life sciences and medical technology company, in 2019. Chicago-based private equity firm GTCR is a partner in the venture.

 

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers